Structure Activity Relationships SARs

The 1,8 naphthyridines, 4-quinolones, cinnolines. fluoroquinolones, and fluorinated naphthyridones, together with their important sidechain substituent modifications and resultant structure-activity relationships are summarized in Table I. Modifications to the nucleus converting the naphthyridine nitrogen in the 8-position to a carbon reduced adverse reactions and increased activity against Gram-positive cocci, including both streptococci and Staphylococcus aureus, whereas either piperazine or other ^-cyclic substitutions at the 7-position significantly increased potency against Gram-negative bacteria, including P

TABLE I A Chemical and Functional Classification of Quinolones and Fluoroquinolones

Structure Name Antibacterial activity Pharmacokinetics Indications/comments

First-generation compounds (often all included as 4-quinolones)

1,8 naphthyridine Nalidixic acid

(carboxylic acid) Piromidic acid 7-methyl 7-pyrrole

1,2-cinnoline Cinoxacin (carboxylic acid)

4-quinoIone (carboxylic acid) Oxolinic acid

7-piperazine (pyrido-pyrimidine) Pipemidic acid P. aeruginosa added

6,7,8 sidechain substituents Name N-l sidechain Antibacterial activity Pharmacokinetics Indications/comments

Enterobacteria only, no Orally absorbed, poor UTI, shigellosis significant anti-Gram- to moderate tissue positive activity penetration

Second-generation compounds (IIA)

A. Fluoroquinolones with enhanced but predominantly Gram-negative activity




Ciprofloxacin Cyclopropyl Pefloxacin Norfloxacin Ofloxacin (Levofloxacin: Rufloxacin

Gram-negative: less active than piperazinyl derivatives

Improved absorption

Limited to UTI

Enhanced anti-Gram nega- High absorption, ++ tissue UTI, STD, enteric infec-

Ethyl Ethyl


1-8 (S) cyclic ring tive potency, including P. aeruginosa plus some limited anti-Gram-positive activity penetration, variable elimination (renal/ metabolic) with moderate to long T/2

tions, RTI (not 1° pneumococcal), invasive Gram-negative infections: osteomyelitis, skin and soft tissue, etc.

6,8-difluoro-7-piperazinyl Lomefloxacin Ethyl

Fleroxacin Fluoro-ethyl

Second-generation compounds (IIB)

B. Fluoroquinolones with balanced broad spectrum activity

6-fluoro-7-piperaziny) 6,8-difluoro-7-dimethylpiperazinyl 6-fluoro-8-chloro-7-pyrrolodinyl 6-fluoro-7-pyrrolidinyl naphthyridone













Third-generation compounds

Fluoroquinolones with enhanced Gram-positive activity

6-fluoro-7-azabicyclo naphthyridone Trovafloxacin Difluorophenyl

6-fluoro-8-methoxy-7-azabicyclo 6-fluoro-8-methoxy-7-piperazinyl and


Moxifloxacin Gatifloxacin

Cyclopropyl Cyclopropyl

Gemifloxacin Cyclopropyl

Lesser anti-Grampositive activity

Long T/2: once daily

Lomefloxacin CNS toxic significantly phototoxic

Enhanced anti-Gram-positive potency, broad-spectrum and anti-pneumococcal activity

Long T/2: once daily high bioavailability, excellent respiratory penetration, few interactions (except grepa-floxacin)

1. All now superseded by more active third-generation agents.

2. Sgnificantly toxic -most withdrawn from clinical use.

Extended activity with ++ anti-pneumococcal and potential anti-anaerobic potency

As for second-generation agents

1. Highly active respiratory quinolones CAP/AECB.

2. Potential for surgical and Ob/Gyn infections.

3. Possible pediatric use.

aeruginosa. These 7-piperazine-substituted compounds, notably pipemidic acid (a pyrido-pyrimidine), were also active against some nalidixic acid-resistant enterobacteria. Subsequent fluorination at the 6-position further improved potency and added clinically exploitable Gram-positive potency [3]. Even more potent compounds were produced by halogenation of the 8-position, notably the 8-chloro derivatives. Unfortunately, these proved highly phototoxic and have mostly been abandoned. Replacement with an 8-methoxy group has yielded the fluoroquinolones moxifloxacin and gatifloxacin, with markedly reduced photo-toxic potential but similarly enhanced potency. Specific molecular configurations, now including several des-fluorinated quinolones (one with an 8-difluoromethoxy substituent), and SARs are discussed in detail in Chapter 2. It is tempting to speculate, however, on the primacy of the 1-cyclopropyl (or 1-8 cyclic) substituent in determining safety from idiosyncratic quinolone toxicity. The only compounds—that is, temafloxacin, tosufloxacin, and trovafloxacin—to depart from this configuration all had 1(2,4)-difluorophenyl substitutions and all proved to have specific, commonly immunologically mediated, severe toxicities. It seems unlikely that new molecules with either this or indeed the 8-chloro configuration will be developed.

Was this article helpful?

0 0
Swine Influenza

Swine Influenza

SWINE INFLUENZA frightening you? CONCERNED about the health implications? Coughs and Sneezes Spread Diseases! Stop The Swine Flu from Spreading. Follow the advice to keep your family and friends safe from this virus and not become another victim. These simple cost free guidelines will help you to protect yourself from the swine flu.

Get My Free Ebook

Post a comment